Chronic lung disease in children due to SARS‐CoV‐2 pneumonia: Case series

Abstract

AbstractThe reported prevalence of chronic lung disease (CLD) due to coronavirus 2 (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2)]) pneumonia with the severe acute respiratory syndrome in children is unknown and rarely reported in English literature. In contrast to most other respiratory viruses, children generally have less severe symptoms when infected with SARS‐CoV‐2. Although only a minority of children with SARS‐CoV‐2 infection require hospitalization, severe cases have been reported. More severe SARS‐CoV‐2 respiratory disease in infants has been reported in low‐ and middle‐income countries (LMICs) compared to high‐income countries (HICs). We describe our experience of five cases of CLD in children due to SARS‐CoV‐2 collected between April 2020 and August 2022. We included children who had a history of a positive SARS‐CoV‐2 polymerase chain reaction (PCR) or antigen test or a positive antibody test in the serum. Three patterns of CLD related to SARS‐CoV‐2 were identified: (1) CLD in infants postventilation for severe pneumonia (n = 3); (2) small airway disease with bronchiolitis obliterans picture (n = 1) and (3) adolescent with adult‐like post‐SARS‐CoV‐2 disease (n = 1). Chest computerized tomography scans showed airspace disease and ground‐glass opacities involving both lungs with the development of coarse interstitial markings seen in four patients, reflecting the long‐term fibrotic consequences of diffuse alveolar damage that occur in children post‐SARS‐CoV‐2 infection. Children with SARS‐CoV‐2 infection mostly have mild symptoms with little to no long‐term sequelae, but the severe long‐term respiratory disease can develop.